Please wait a minute...
文章检索
预防医学  2025, Vol. 37 Issue (11): 1113-1118    DOI: 10.19485/j.cnki.issn2096-5087.2025.11.007
  体重管理与肥胖防控专题 本期目录 | 过刊浏览 | 高级检索 |
超重、肥胖、中心性肥胖与高血压的关系研究
叶振淼, 张默涵, 樊丽辉, 谢轶敏, 姜雪霞, 郑宇航, 罗永园, 夏喆铮, 金茜, 孙倩
温州市疾病预防控制中心(温州市卫生监督所),浙江 温州 325000
Association between overweight, obesity, central obesity and hypertension
YE Zhenmiao, ZHANG Mohan, FAN Lihui, XIE Yimin, JIANG Xuexia, ZHENG Yuhang, LUO Yongyuan, XIA Zhezheng, JIN Xi, SUN Qian
Wenzhou Center for Disease Control and Prevention (Wenzhou Institute of Public Health Supervision), Wenzhou, Zhejiang 325000, China
全文: PDF(833 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解超重、肥胖、中心性肥胖与高血压的关系,为制定针对性的高血压防控策略提供依据。方法 于2023年6月—2024年8月,采用多阶段随机整群抽样方法抽取浙江省温州市≥18岁常住居民为调查对象,通过问卷调查、体格检查和实验室检测收集人口学信息、生活方式、身高、体重、腰围(WC)、血压和血生化指标等资料;分析高血压患病率,采用2010年第六次全国人口普查数据进行标化。计算体质指数(BMI)判定超重、肥胖,以WC判定中心性肥胖;采用多因素logistic回归模型分析超重、肥胖、中心性肥胖与高血压的关系。结果 调查38 593人,男性19 481人,占50.48%;女性19 112人,占49.52%。年龄MQR)为46.00(26.00)岁。超重12 634人,占32.74%;肥胖3 963人,占10.27%。中心性肥胖10 755人,占27.87%。高血压11 813例,患病率为30.61%,标化患病率为24.41%。多因素logistic回归分析结果显示,调整人口学信息、生活方式、糖尿病和血脂异常后,超重和肥胖居民高血压患病可能性分别是BMI正常居民的1.927(95%CI:1.815~2.045)倍和3.724(95%CI:3.404~4.073)倍;中心性肥胖居民高血压患病可能性是WC正常居民的2.346(95%CI:2.214~2.486)倍;仅中心性肥胖、仅超重、超重伴中心性肥胖、仅肥胖和肥胖伴中心性肥胖居民高血压患病可能性分别是BMI联合WC正常居民的1.586(95%CI:1.391~1.809)倍、1.704(95%CI:1.582~1.835)倍、2.433(95%CI:2.254~2.626)倍、1.768(95%CI:1.424~2.194)倍和4.466(95%CI:4.053~4.921)倍。结论 超重、肥胖和中心性肥胖均与成年居民高血压有关,其中全身性肥胖伴中心性肥胖的成年居民高血压患病可能性较高。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
叶振淼
张默涵
樊丽辉
谢轶敏
姜雪霞
郑宇航
罗永园
夏喆铮
金茜
孙倩
关键词 高血压超重肥胖中心性肥胖    
AbstractObjective To investigate the association between overweight, obesity, central obesity and hypertension, so as to provide the basis for formulating targeted hypertension prevention and control strategies. Methods Permanent residents aged ≥18 years were selected in Wenzhou City, Zhejiang Province from June 2023 to August 2024 by a multistage cluster random sampling method. Data on demographic information, lifestyle, height, weight, waist circumference (WC), blood pressure, and blood biochemical indicators were collected through questionnaire surveys, physical examinations, and laboratory tests. The prevalence of hypertension was calculated and standardized using the data of the Sixth National Population Census in 2010. Body mass index (BMI) was calculated to determine overweight and obesity, while WC was used to identify central obesity. The association between overweight, obesity, central obesity and hypertension were analyzed using multivariable logistic regression models. Results A total of 38 593 residents were surveyed, including 19 481 (50.48%) males and 19 112 (49.52%) females. The median age was 46.00 (interquartile range, 26.00) years. The rates of overweight, obesity, and central obesity were 32.74% (12 634 individuals), 10.27% (3 963 individuals), and 27.87% (10 755 individuals), respectively. There were 11 813 cases of hypertension, with a prevalence and standardized prevalence of 30.61% and 24.41%, respectively. Multivariable logistic regression analysis showed that after adjusting for demographic information, lifestyle, diabetes and dyslipidemia, the likelihood of hypertension in the overweight and obesity groups was 1.927 (95%CI: 1.815-2.045) times and 3.724 (95%CI: 3.404-4.073) times that of the normal BMI group, respectively. The likelihood of hypertension in the central obesity group was 2.346 (95%CI: 2.214-2.486) times that of the normal WC group. The likelihood of hypertension in the central obesity only, overweight only, overweight with central obesity, obesity only and obesity with central obesity groups was 1.586 (95%CI: 1.391-1.809), 1.704 (95%CI: 1.582-1.835), 2.433 (95%CI: 2.254-2.626), 1.768 (95%CI: 1.424-2.194), and 4.466 (95%CI: 4.053-4.921) times that of the normal BMI and WC group, respectively. Conclusions Overweight, obesity and central obesity were all associated with hypertension among adult residents. The highest likelihood of hypertension was observed among adult residents with both general obesity and central obesity.
Key wordshypertension    overweight    obesity    central obesity
收稿日期: 2025-09-08      修回日期: 2025-11-02     
中图分类号:  R544.1  
基金资助:温州市科技计划项目(Y2023032)
作者简介: 叶振淼,硕士,副主任医师,主要从事慢性病预防控制工作
通信作者: 张默涵,E-mail:506518631@qq.com   
引用本文:   
叶振淼, 张默涵, 樊丽辉, 谢轶敏, 姜雪霞, 郑宇航, 罗永园, 夏喆铮, 金茜, 孙倩. 超重、肥胖、中心性肥胖与高血压的关系研究[J]. 预防医学, 2025, 37(11): 1113-1118.
YE Zhenmiao, ZHANG Mohan, FAN Lihui, XIE Yimin, JIANG Xuexia, ZHENG Yuhang, LUO Yongyuan, XIA Zhezheng, JIN Xi, SUN Qian. Association between overweight, obesity, central obesity and hypertension. Preventive Medicine, 2025, 37(11): 1113-1118.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2025.11.007      或      http://www.zjyfyxzz.com/CN/Y2025/V37/I11/1113
[1] 国家心血管病中心.中国心血管健康与疾病报告2021[M].北京:科学出版社,2022.
National Center for Cardiovascular Disease.Annual report on cardiovascular health and diseases in China[M].Beijing:Science Press,2022.(in Chinese)
[2] 刘明波,何新叶,杨晓红,等.《中国心血管健康与疾病报告2024》要点解读[J].临床心血管病杂志,2025,41(7):492-511.
LIU M B,HE X Y,YANG X H,et al.Interpretation of Annual Report on Cardiovascular Health and Diseases in China 2024[J].J Clin Cardiol,2025,41(7):492-511.(in Chinese)
[3] 中国高血压防治指南修订委员会,高血压联盟(中国),中国医疗保健国际交流促进会高血压分会,等.中国高血压防治指南(2024年修订版)[J].中华高血压杂志(中英文),2024,32(7):603-700.
Revision Committee of Chinese Guidelines for the Prevention and Treatment of Hypertension,Hypertension League of China,Hypertension Branch of China International Exchange and Promotive Association for Medical and Health Care,et al.Chinese guidelines for the prevention and treatment of hypertension(2024 revised edition)[J].Chin J Hypertens,2024,32(7):603-700.(in Chinese)
[4] 席朋林. 保定市C社区中老年居民高血压、糖尿病、高血脂、高尿酸血症患病情况及影响因素分析[D].保定:河北大学,2024.
XI P L.Analysis on the prevalence and influencing factors of hypertension,diabetes,hyperlipidemia and hyperruricemia in C community of Baoding City[D].Baoding:Hebei University,2024.(in Chinese)
[5] 中华人民共和国国家卫生和计划生育委员会.国家基本公共卫生服务规范(第三版)[Z/OL].[2025-11-02].https://www.nhc.gov.cn/ewebeditor/uploadfile/2017/04/20170417104506514.pdf.
National Health and Family Planning Commission.National basic public health service guidelines(third edition)[Z/OL].[2025-11-02].https://www.nhc.gov.cn/ewebeditor/uploadfile/2017/04/20170417104506514.pdf.(in Chinese)
[6] 《运动处方中国专家共识(2023)》专家组.运动处方中国专家共识(2023)[J].中国运动医学杂志,2023,42(1):3-13.
Expert panel on Chinese Expert Consensus on Exercise Prescription(2023).China expert consensus on exercise prescription(2023)[J].Chin J Phys Med,2023,42(1):3-13.(in Chinese)
[7] 袁亚运. 2016–2020年中国成年人长期睡眠状况及影响因素研究[J].中国慢性病预防与控制,2025,33(5):369-374.
YUAN Y Y.Study on long-term sleep status and influencing factors of adults in China from 2016 to 2020[J].Chin J Prev Control Chronic Dis,2025,33(5):369-374.(in Chinese)
[8] 中国营养学会.中国居民膳食指南(2022)[M].北京:人民卫生出版社,2022.
Chinese Nutrition Society.Dietary guide for China residents(2022)[M].Beijing:People's Medical Publishing House,2022.(in Chinese)
[9] 中国营养学会肥胖防控分会,中国营养学会临床营养分会,中华预防医学会行为健康分会,等.中国居民肥胖防治专家共识[J].中国预防医学杂志,2022,23(5):321-339.
Chinese Nutrition Society Obesity Prevention and Control Section,Chinese Nutrition Society Clinical Nutrition Section,Chinese Preventive Medicine Association Behavioral Health Section,et al.Consensus of experts on prevention and treatment of obesity among residents in China[J].Chin Prev Med,2022,23(5):321-339.(in Chinese)
[10] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)(上)[J].中国实用内科杂志,2021,41(8):668-695.
Chinese Diabetes Society.Guidelines for the prevention and treatment of type 2 diabetes mellitus in China(2020 edition)(Part 1)[J].Chin J Pract Intern Med,2021,41(8):668-695.(in Chinese)
[11] 诸骏仁,高润霖,赵水平,等.中国成人血脂异常防治指南(2016年修订版)[J].中国循环杂志,2016,31(10):937-953.
ZHU J R,GAO R L,ZHAO S P,et al.Guidelines for prevention and treatment of dyslipidemia in adults in China(2016 revised edition)[J].Chin Circ J,2016,31(10):937-953.(in Chinese)
[12] 胡鸿宝,李小成,郭宝福,等.南京市城乡居民高血压流行现状及防治对策探讨[J].江苏预防医学,2018,29(6):685-686.
HU H B,LI X C,GUO B F,et al.Prevalence of hypertension among urban and rural residents in Nanjing and its prevention and control countermeasures[J].Jiangsu J Prev Med,2018,29(6):685-686.(in Chinese)
[13] 方家煜,郭子宏,付宏晨,等.2015—2021年云南省成年居民高血压流行变化情况[J].中国慢性病预防与控制,2023,31(6):411-415.
FANG J Y,GUO Z H,FU H C,et al.The prevalence change of hypertension in adults of Yunnan Province from 2015 to 2021[J].Chin J Prev Control Chronic Dis,2023,31(6):411-415.(in Chinese)
[14] 林修全,陈铁晖,林熙,等.福建省成人高血压患病情况及其影响因素分析[J].中国卫生统计,2021,38(4):589-592,596.
LIN X Q,CHEN T H,LIN X,et al.Prevalence and influencing factors of hypertension among adults in Fujian Province[J].Chin J Health Stat,2021,38(4):589-592,596.(in Chinese)
[15] 张娜,邵永强,张好,等.温州市成年居民高血压患病率及影响因素分析[J].中国公共卫生管理,2020,36(6):813-816.
ZHANG N,SHAO Y Q,ZHANG H,et al.Investigation on prevalence rate and impact factors of hypertension among adult residents in Wenzhou City[J].Chin J PHM,2020,36(6):813-816.(in Chinese)
[16] 龚海英,薛凤玉,刘晓芬,等.18~79岁居民高血压风险预测模型研究[J].预防医学,2025,37(10):1075-1080.
GONG H Y,XUE F Y,LIU X F,et al.A prediction model for hypertension risk among residents aged 18 to 79 years[J].China Prev Med J,2025,37(10):1075-1080.(in Chinese)
[17] 郭向娇,李建彬,武恩平,等.郑州市40~79岁居民高血压患病及影响因素分析[J].预防医学,2020,32(3):304-306.
GUO X J,LI J B,WU E P,et al.Prevalence and influencing factors of hypertension among residents aged 40-79 in Zhengzhou City[J].China Prev Med J,2020,32(3):304-306.(in Chinese)
[18] 李意昌,杨秀勤,陈月婵,等.佛山市南海区中老年居民BMI指数、腰围与高血压和糖尿病以及血脂异常的关系[J].广州医科大学学报,2021,49(1):47-50.
LI Y C,YANG X Q,CHEN Y C,et al.Correlation of BMI and waist circumference with hypertension,diabetes and dyslipidemia among middle-aged and elderly residents in Nanhai District,Foshan[J].Acad J Guangzhou Med Univ,2021,49(1):47-50.(in Chinese)
[19] 陆杰,张柯,吴雅,等.肥胖指标预测2型糖尿病患者心脑血管疾病的效果比较[J].预防医学,2025,37(9):886-891.
LU J,ZHANG K,WU Y,et al.Comparison of the effect of obesity indicators in predicting cardiovascular and cerebrovascular diseases among patients with type 2 diabetes mellitus[J].China Prev Med J,2025,37(9):886-891.(in Chinese)
[20] 韩延柏,汪宏莉,陈涛,等.辽宁省20~39岁成人肥胖状况、血压水平及其关联性[J].中国公共卫生,2019,35(8):1067-1072.
HAN Y B,WANG H L,CHEN T,et al.Obesity status and blood pressure level and their interrelationship among 20-39 years old residents in Liaoning Province[J].Chin J Public Health,2019,35(8):1067-1072.(in Chinese)
[21] 韩泽乾,陈郁,朱桐,等.BMI过低会显著增加高血压的发病风险:基于重庆某医院大数据的横断面研究[J].解放军预防医学杂志,2020,38(4):1-5.
HAN Z Q,CHEN Y,ZHU T,et al.Low BMI will significantly increase the risk of hypertension:a cross-sectional study based on big data from a hospital in Chongqing[J].J Prev Med Chin People's Liberation Army,2020,38(4):1-5.(in Chinese)
[22] GU P,XU A M.Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction[J].Rev Endocr Metab Disord,2013,14(1):49-58.
[1] 陆杰, 张柯, 吴雅, 王玥, 张玥, 陆叶, 吴周理, 任志华, 黄艺文. 肥胖指标预测2型糖尿病患者心脑血管疾病的效果比较[J]. 预防医学, 2025, 37(9): 886-891.
[2] 张一, 李梦迪, 石亚锋, 苗超. 余姚市中小学生超重和肥胖现况调查[J]. 预防医学, 2025, 37(9): 955-958.
[3] 周梦怡, 苏丹婷, 何梦洁, 徐沛维, 韩丹, 黄李春, 章荣华. 植物性饮食与不同肥胖类型的关联研究[J]. 预防医学, 2025, 37(8): 773-778.
[4] 孟杨, 万金豹, 吴萃, 陈秋艳, 严青华, 程旻娜. 上海市农村高血压患者高血压知信行及家庭血压测量调查[J]. 预防医学, 2025, 37(7): 737-742.
[5] 黄阳梅, 沈旭娟, 谢董颖, 张琦, 郑子聪, 王勐. 小学生体重监测信息反馈干预的效果评价[J]. 预防医学, 2025, 37(6): 541-545.
[6] 蒋安然, 朱煜典, 鲁芬, 方大春, 翟光富. 膳食行为与中学生超重肥胖的关联研究[J]. 预防医学, 2025, 37(4): 341-345.
[7] 李倩, 杨柏林, 陈积标, 尹寒露, 许祝平, 孟晓军. 无锡市50岁及以上HIV/AIDS抗病毒治疗病例自报慢性病资料分析[J]. 预防医学, 2025, 37(4): 390-394.
[8] 王启开, 弭亚楠, 刘好, 林嘉浩, 杨鑫源, 王越, 金千靖, 宋照猛. 高血压肾病患者膳食干预效果评价[J]. 预防医学, 2025, 37(4): 373-377.
[9] 江南, 唐晓敏, 孙文韬. 膳食模式与中小学生超重肥胖的关联研究[J]. 预防医学, 2025, 37(3): 228-232.
[10] 缪彩云, 覃玉, 万亚男, 陈路路, 崔岚, 王小莉. 江苏省居民自测血压行为及影响因素分析[J]. 预防医学, 2025, 37(3): 223-227.
[11] 陈海苗, 马岩, 刘明奇, 马珊珊, 李军, 方益荣. 儿童期肥胖与2型糖尿病、冠心病的孟德尔随机化研究[J]. 预防医学, 2025, 37(3): 307-311.
[12] 叶真. 系统变革:超重肥胖防治新策略[J]. 预防医学, 2025, 37(11): 1081-1086.
[13] 陈向宇, 王蒙, 胡如英, 关云琦, 梁明斌, 何青芳, 姚伟元, 钟节鸣. 2015—2023年浙江省成年居民超重肥胖流行趋势[J]. 预防医学, 2025, 37(11): 1093-1098.
[14] 何易阳, 王碧莲, 张萍萍, 励丽. 膳食质量与小学生超重肥胖的关系研究[J]. 预防医学, 2025, 37(11): 1099-1102.
[15] 徐春霞, 丁亚君, 袁芸芸, 周亚春, 潘晓华, 张晶晶, 陈丽丽. 北仑区多学科综合体重管理干预效果评价[J]. 预防医学, 2025, 37(11): 1103-1107,1112.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed